Growth Metrics

Thermo Fisher Scientific (TMO) Non-Current Deferred Tax Liability (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Non-Current Deferred Tax Liability readings, the most recent being $2.1 billion for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 102.4% to $2.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.1 billion, a 102.4% increase, with the full-year FY2025 number at $1.5 billion, up 17.74% from a year prior.
  • Non-Current Deferred Tax Liability hit $2.1 billion in Q1 2026 for Thermo Fisher Scientific, up from $1.5 billion in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $3.5 billion in Q2 2022 to a low of $624.0 million in Q2 2025.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $1.9 billion (2023), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 114.33% in 2022 and later plummeted 58.84% in 2025.
  • Thermo Fisher Scientific's Non-Current Deferred Tax Liability stood at $2.8 billion in 2022, then crashed by 32.54% to $1.9 billion in 2023, then tumbled by 34.03% to $1.3 billion in 2024, then increased by 17.74% to $1.5 billion in 2025, then soared by 41.13% to $2.1 billion in 2026.
  • The last three reported values for Non-Current Deferred Tax Liability were $2.1 billion (Q1 2026), $1.5 billion (Q4 2025), and $842.0 million (Q3 2025) per Business Quant data.